Arrowhead Research Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
Due Diligence for Asset Managers
You have viewed 10 of the 10 daily limit
Subscribe for $29/month to gain full access
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Arrowhead Research Corp
TickerARWR
CIK #0000879407
CUSIP04280A100
SectorTrade & Services - Services-Commercial Physical & Biological Research
Address201 South Lake Avenue Suite 703, Pasadena, CA 91101
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Arrowhead Research Corp 2013-10-22 64.0 M Exemption: 506(b) · Minimum: $3,000,000 · Duration: One year or less · Commission: $3,840,000 · Revenue: $1 - $1,000,000
CIK Filing 2011 - 2026
[0000879407] 10-K
[0000879407] 10-Q
[0000879407] 3
[0000879407] 4
[0000879407] 5
[0000879407] 8-K
[0000879407] D
[0000879407] SC 13D
[0000879407] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
FMR LLC Arrowhead Pharmaceuticals Inc [2026-05-06] 0.0
Vanguard Capital Management LLC Arrowhead Pharmaceuticals Inc [2026-04-29] 0.0
Vanguard Portfolio Management LLC Arrowhead Pharmaceuticals Inc [2026-04-28] 0.0
State Street Corp Arrowhead Pharmaceuticals Inc [2025-08-11] 0.0
State Street Corp Arrowhead Pharmaceuticals Inc [2025-05-13] 0.0
Sarepta Therapeutics Inc Arrowhead Pharmaceuticals Inc [2025-02-14] 0.0
State Street Corp Arrowhead Pharmaceuticals Inc [2025-02-05] 0.0
Avoro Capital Advisors LLC Arrowhead Pharmaceuticals Inc [2024-11-14] 7.2
BlackRock Inc Arrowhead Pharmaceuticals Inc [2023-01-20] 12.0
Vanguard Group Inc Arrowhead Pharmaceuticals Inc [2019-10-10] 11.37
State Street Corp Arrowhead Pharmaceuticals Inc [2019-02-13] 5.5
First Manhattan Co Arrowhead Pharmaceuticals Inc [2019-02-11] 6.33
BlackRock Inc Arrowhead Pharmaceuticals Inc [2019-02-08] 7.8
RTW Investments LP Arrowhead Pharmaceuticals Inc [2018-05-14] 5.02
OppenheimerFunds Inc Arrowhead Pharmaceuticals Inc [2018-02-06] 8.42
Silence Therapeutics PLC Arrowhead Pharmaceuticals Inc [2017-12-01] 6.4
Silence Therapeutics PLC Arrowhead Pharmaceuticals Inc [2017-01-13] 0.21
Novartis AG Arrowhead Research Corp [2016-02-12] 5.57
Integrated Core Strategies US LLC Arrowhead Research Corp [2015-04-07] 3.6
BlackRock Inc Arrowhead Research Corp [2015-02-02] 6.2
Oppenheimer Funds Inc Arrowhead Research Corp [2015-01-26] 5.49
Bridger Management LLC Arrowhead Research Corp [2015-01-23] 5.5
Integrated Core Strategies US LLC Arrowhead Research Corp [2014-04-08] 3.0
FMR LLC Arrowhead Research Corp [2014-03-10] 0.0
Baker Bros Advisors LP Arrowhead Research Corp [2014-02-14] 9.99
OrbiMed Advisors LLC Arrowhead Research Corp [2014-02-13] 1.6
Marxe Austin W & Greenhouse David M Arrowhead Research Corp [2014-02-12] 9.99
QVT Financial LP Arrowhead Research Corp [2013-10-18] 5.64
Ridgeback Capital Investments LP Arrowhead Research Corp [2013-10-16] 5.0
SAC Capital Advisors LP Arrowhead Research Corp [2013-10-15] 3.9
Sabby Management LLC Arrowhead Research Corp [2013-05-13] 6.99
RA Capital Management LLC Arrowhead Research Corp [2013-05-09] 0.9
Camber Capital Management LLC Arrowhead Research Corp [2013-05-09] 9.9
Sabby Management LLC Arrowhead Research Corp [2012-08-16] 6.67
Form 3/4/5 Filer 2011 - 2026
Arrowhead Pharmaceuticals Inc
Cohen Matthew Gregory
Lu Hongbo
Hamilton James C
Apel Daniel Joseph
O'Brien Patrick
Anzalone Christopher Richard
Ferrari Mauro
Olukotun Adeoye Y
Waddill William D
Vakiener Victoria
Ingram Douglas S
Perry Michael S
Myszkowski Kenneth Allen
Given Douglas B
Oliver Tracie
San Martin Javier
de Backer Marianne
Hassard James
Bradshaw Curt
Given Bruce D
Li Zhen
Leone Peter Brian
Frykman Edward W
Lewis David L
McKenney Charles
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Hamilton James C
Common Stock
2026-03-05 Sell 10,000 $64.19 641,900
O'Brien Patrick
Common Stock
2026-01-06 Gift 540 $0.00
O'Brien Patrick
Common Stock
2026-01-06 Grant 75,000 $0.00
O'Brien Patrick
Common Stock
2026-01-06 Gift 440 $0.00
Apel Daniel Joseph
Common Stock
2026-01-06 Grant 75,000 $0.00
O'Brien Patrick
Common Stock
2026-01-06 Gift 540 $0.00
O'Brien Patrick
Common Stock
2026-01-06 Gift 440 $0.00
Hamilton James C
Common Stock
2026-01-06 Grant 75,000 $0.00
O'Brien Patrick
Common Stock
2026-01-06 Gift 540 $0.00
Hamilton James C
Common Stock
2026-01-05 Sell 12,711 $63.95 812,868
O'Brien Patrick
Common Stock
2026-01-05 Sell 2,336 $64.04 149,597
O'Brien Patrick
Common Stock
2026-01-05 Sell 46 $68.00 3,128
Hamilton James C
Common Stock
2026-01-05 Sell 6,090 $62.28 379,285
Hamilton James C
Common Stock
2026-01-05 Sell 309 $68.00 21,012
O'Brien Patrick
Common Stock
2026-01-05 Sell 313 $68.00 21,284
O'Brien Patrick
Common Stock
2026-01-05 Sell 6,164 $62.23 383,586
O'Brien Patrick
Common Stock
2026-01-05 Sell 600 $61.12 36,672
O'Brien Patrick
Common Stock
2026-01-05 Sell 900 $62.25 56,025
O'Brien Patrick
Common Stock
2026-01-05 Sell 4,368 $61.20 267,322
O'Brien Patrick
Common Stock
2026-01-05 Sell 2,700 $64.44 173,988
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 444 121,926,920
2025-12-31 409 117,626,706
2025-09-30 308 112,820,141
2025-06-30 283 106,166,100
2025-03-31 267 103,357,973
2024-12-31 272 98,157,305
2024-09-30 276 96,898,476
2024-06-30 275 99,235,600
2024-03-31 280 101,010,086
2023-12-31 270 81,996,786
2023-09-30 257 74,818,003
2023-06-30 278 72,548,591
Form 13F Holdings
Firm Period DFND Voting Shares
Assenagon Asset Management SA [2026-06-30] SOLE 201,927 201,927
Louisiana State Employees Retirement System [2026-06-30] SOLE 40,600 40,600
Y-Intercept Hong Kong Ltd [2026-06-30] SOLE 40,231 40,231
Yousif Capital Management LLC [2026-06-30] SOLE 12,789 40,203
Commonwealth of Pennsylvania Public School Empls Retrmt SYS [2026-06-30] SOLE 33,721 33,721
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 87 21,689
Independent Financial Group LLC [2026-06-30] SOLE 0 14,410
Alaska Retirement Management Board [2026-06-30] SOLE 13,802 13,802
Farther Finance Advisors LLC [2026-06-30] SOLE 0 12,088
Crossmark Global Holdings Inc [2026-06-30] SOLE 8,868 8,868
IFP Advisors LLC [2026-06-30] SOLE 8,139 8,139
Brown Miller Wealth Management LLC [2026-06-30] OTR 0 6,269
Financial Enhancement Group LLC [2026-06-30] SOLE 0 5,500
Merit Financial Group LLC [2026-06-30] SOLE 0 5,445
TEMA ETFS LLC [2026-06-30] SOLE 5,263 5,263
QRG Capital Management Inc [2026-06-30] SOLE 4,810 4,810
Linden Thomas Advisory Services LLC [2026-06-30] SOLE 0 4,292
Fifth Third Wealth Advisors LLC [2026-06-30] SOLE 4,181 4,181
Merit Financial Group LLC [2026-06-30] OTR 0 4,128
Grimes & Company Inc [2026-06-30] SOLE 1,968 3,985
Gamma Investing LLC [2026-06-30] DFND 3,879 3,879
Gateway Investment Advisers LLC [2026-06-30] SOLE 3,768 3,768
Sequoia Financial Advisors LLC [2026-06-30] SOLE 0 3,629
Goldstein Advisors LLC [2026-06-30] SOLE 0 3,566
Corecap Advisors LLC [2026-06-30] SOLE 0 3,000
PSP Research LLC [2026-06-30] SOLE 0 2,600
LRI Investments LLC [2026-06-30] SOLE 2,186 2,186
Harbor Investment Advisory LLC [2026-06-30] SOLE 1,285 1,285
First Horizon Corp [2026-06-30] DFND 12 1,088
Owl Creek Wealth Partners LLC [2026-06-30] SOLE 0 615
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com